Chemoinformaics analysis of 3,9-Dihydroxypterocarpan
Molecular Weight | 256.257 | nRot | 0 |
Heavy Atom Molecular Weight | 244.161 | nRig | 20 |
Exact Molecular Weight | 256.074 | nRing | 4 |
Solubility: LogS | -3.739 | nHRing | 2 |
Solubility: LogP | 2.618 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
nHA | 4 | APOL | 36.2595 |
nHD | 2 | BPOL | 15.5105 |
QED | 0.761 |
Synth | 3.279 |
Natural Product Likeliness | 2.007 |
NR-PPAR-gamma | 0.018 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.004 |
Pgp-sub | 0.018 |
HIA | 0.006 |
CACO-2 | -4.793 |
MDCK | 0.00000886 |
BBB | 0.049 |
PPB | 0.968381 |
VDSS | 0.741 |
FU | 0.0350912 |
CYP1A2-inh | 0.928 |
CYP1A2-sub | 0.822 |
CYP2c19-inh | 0.81 |
CYP2c19-sub | 0.233 |
CYP2c9-inh | 0.784 |
CYP2c9-sub | 0.948 |
CYP2d6-inh | 0.852 |
CYP2d6-sub | 0.894 |
CYP3a4-inh | 0.714 |
CYP3a4-sub | 0.333 |
CL | 12.39 |
T12 | 0.598 |
hERG | 0.081 |
Ames | 0.898 |
ROA | 0.159 |
SkinSen | 0.914 |
Carcinogencity | 0.613 |
EI | 0.902 |
Respiratory | 0.407 |
NR-Aromatase | 0.379 |
Antiviral | No |
Prediction | 0.680182 |